We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.59B
1-Year Est. Return
234.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.46%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$1.91B
AUM Growth
-$296M
(-13%)
Cap. Flow
-$354M
Cap. Flow
% of AUM
-18.46%
Top 10 Holdings %
Top 10 Hldgs %
80.8%
Holding
37
New
1
Increased
1
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ardelyx
ARDX
|
+$58.9M |
| 2 |
ORKA
Oruka Therapeutics
ORKA
|
+$8.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
+$109M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$97.6M |
| 3 |
CVT
CVENT, INC.
CVT
|
+$74.9M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
+$57.4M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.84% |
| 2 | Communication Services | 12.3% |
| 3 | Technology | 8.79% |
| 4 | Miscellaneous | 3.07% |
| 5 | Consumer Discretionary | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$829M
| $10.4M | 0.54% |
324,315
| – | – |
|
|
ROKA
27
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $8.37M | 0.44% |
322,043
| – | – |
|
28
Exelixis
EXEL
$14.1B
| $8.3M | 0.43% |
2,207,000
| – | – |
|
29
Aurinia Pharmaceuticals
AUPH
$2.15B
| $7.69M | 0.4% |
2,546,843
| – | – |
|
|
ECOM
30
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $6.65M | 0.35% |
556,692
| – | – |
|
|
CVT
31
DELISTED
CVENT, INC.
CVT
| $6.29M | 0.33% |
244,106
-2,752,632
| -92% | -$74.9M |
|
|
PRTK
32
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.48M | 0.23% |
173,892
| – | – |
|
|
ARQL
33
DELISTED
Arqule Inc
ARQL
| $4.03M | 0.21% |
2,520,316
| – | – |
|
|
AGRX
34
DELISTED
Agile Therapeutics
AGRX
| $1.15M | 0.06% |
67
| – | – |
|
|
NURO
35
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| – | – |
-22
| Closed | -$96K |
|
|
WIFI
36
DELISTED
Boingo Wireless, Inc.
WIFI
| – | – |
-2,496,312
| Closed | -$18.8M |
|
|
HPTX
37
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| – | – |
-2,384,221
| Closed | -$109M |
|
Similar funds
ADL
CCP
ACM
SW
GCP
W
PIS
FWP
NEA Management Company's Q2 2015 Portfolio in Review
As of Q2 2015, NEA Management Company held 37 positions worth $1.91B, down 13% from $2.21B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
NEA Management Company withdrew a net $354M in Q2 2015, closing 3 positions and reducing 6 holdings. Its most notable exit was HYPERION THERAPEUTICS INC COM STK (DE), an estimated $109M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 65% a quarter earlier, followed by Communication Services and Technology.
Against the trend, NEA Management Company opened a new position in Oruka Therapeutics worth $11.8M.
- NEA Management Company's largest Q2 2015 buy was Oruka Therapeutics: 6,760 shares worth $11.8M.
- NEA Management Company added most to Ardelyx in Q2 2015, an estimated $58.9M increase.
- NEA Management Company's biggest Q2 2015 reduction was Clovis Oncology, Inc., cutting an estimated $97.6M.
- NEA Management Company fully exited HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2015, selling an estimated $109M.
- NEA Management Company's ten largest holdings make up 81% of its $1.91B portfolio in Q2 2015.
- NEA Management Company opened 1 new position and closed 3 in Q2 2015.
- NEA Management Company's portfolio value fell 13% quarter-over-quarter to $1.91B.
Based on NEA Management Company's 13F filing for Q2 2015, filed 15 Jul 2015.